Published in Gastroenterology on March 24, 2010
Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med (2012) 2.33
Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol (2012) 1.05
The lung in liver disease: old problem, new concepts. Trans Am Clin Climatol Assoc (2013) 0.89
Pathophysiology of lung injury induced by common bile duct ligation in mice. PLoS One (2014) 0.84
Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS). PLoS One (2014) 0.81
Pharmacological treatment for hepatopulmonary syndrome. Biomed Res Int (2013) 0.80
Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans. Dig Dis Sci (2011) 0.80
Cirrhosis and hepatopulmonary syndrome. World J Gastroenterol (2014) 0.77
The association between clinical symptoms, laboratory findings and serum endothelin 1 concentrations, in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterol Hepatol Bed Bench (2012) 0.75
Variability of oxygenation in possible hepatopulmonary syndrome: effects of requiring two abnormal arterial blood gas results for diagnosis. Dig Dis Sci (2015) 0.75
Hepatopulmonary syndrome: is it naïve or enlightening when genetic associations match clinical perspective? Gastroenterology (2010) 0.75
The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk. Antioxidants (Basel) (2017) 0.75
Familial hepatopulmonary syndrome in common variable immunodeficiency. J Clin Immunol (2015) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet (1994) 6.50
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood (2004) 5.71
European population substructure: clustering of northern and southern populations. PLoS Genet (2006) 5.27
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet (1996) 5.15
Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol (2007) 4.50
Quantitative trait Loci analysis using the false discovery rate. Genetics (2005) 3.69
A principal components regression approach to multilocus genetic association studies. Genet Epidemiol (2008) 2.89
Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J (2004) 2.80
Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med (2000) 2.43
Improved correction for population stratification in genome-wide association studies by identifying hidden population structures. Genet Epidemiol (2008) 2.23
The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology (1997) 2.14
Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology (2005) 2.05
Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology (2007) 1.87
Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology (1997) 1.74
Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology (2006) 1.66
Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med (1999) 1.63
NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. Am J Physiol Lung Cell Mol Physiol (2008) 1.52
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology (2008) 1.50
Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J (1995) 1.47
Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost (2007) 1.46
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology (2008) 1.23
The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology (2004) 1.21
Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1alpha. J Biol Chem (2007) 1.17
Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology (2003) 1.16
Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology (2006) 1.05
Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases. Cell Signal (2009) 0.99
Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol (2002) 0.99
Endostatin: current concepts about its biological role and mechanisms of action. Biochemistry (Mosc) (2007) 0.97
Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med (2005) 0.95
Lung capillary changes in hepatic cirrhosis in rats. Am J Physiol (1997) 0.95
Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology (2005) 0.92
Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3. Oncogene (2005) 0.92
Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha. Oncogene (2007) 0.91
Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes (2005) 0.88
Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients. Eur Respir J (2009) 0.83
Role of hematopoietic stem cells in angiogenesis. Int J Hematol (2001) 0.79
The effects of serum estrogen levels on hypoxemia and blood nitric oxide levels in experimental hepatopulmonary syndrome. Hepatol Res (2005) 0.78
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA (2006) 8.16
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med (2010) 5.70
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology (2006) 4.90
Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med (2008) 4.71
Incidence of treated cardiac arrest in hospitalized patients in the United States. Crit Care Med (2011) 4.43
Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE. Nucleic Acids Res (2003) 4.29
GeneCards 2002: towards a complete, object-oriented, human gene compendium. Bioinformatics (2002) 4.24
A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22
Burden of liver disease in the United States: summary of a workshop. Hepatology (2002) 4.00
The Budd-Chiari syndrome. N Engl J Med (2004) 3.95
Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2004) 3.63
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial. Hepatology (2007) 3.57
Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol (2007) 3.48
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology (2007) 3.40
Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2013) 3.38
Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology (2014) 3.29
Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol (2005) 3.29
Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest (2007) 3.22
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med (2015) 3.13
Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study. Diabetes Care (2013) 3.05
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Clinical practice. Microscopic hematuria. N Engl J Med (2003) 2.96
Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg (2009) 2.95
Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet (2009) 2.85
Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Am J Psychiatry (2007) 2.84
Pulmonary arteriovenous malformations. Chest (2013) 2.77
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77
A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy. Am J Gastroenterol (2002) 2.75
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69
Cardiovascular disease and subsequent kidney disease. Arch Intern Med (2007) 2.65
Clinical risk factors for portopulmonary hypertension. Hepatology (2008) 2.62
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest (2005) 2.60
Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Am J Gastroenterol (2002) 2.55
Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol (2012) 2.55
Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection. J Infect Dis (2009) 2.53
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res (2003) 2.50
Portopulmonary hypertension and hepatopulmonary syndrome. Lancet (2004) 2.48
Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology (2010) 2.48
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med (2009) 2.43
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med (2012) 2.42
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol (2008) 2.40
Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology (2003) 2.38
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology (2013) 2.35
Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med (2012) 2.33
Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol (2006) 2.32
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology (2014) 2.28
Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation (2008) 2.28
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol (2002) 2.25
Steroid use in acute liver failure. Hepatology (2013) 2.23
Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation (2012) 2.19
The homocysteine hypothesis of depression. Am J Psychiatry (2007) 2.17
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis (2006) 2.16
Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol (2012) 2.14
Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates. Liver Transpl (2007) 2.13
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol (2004) 2.12
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med (2011) 2.11
Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst (2005) 2.10
Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology (2005) 2.05
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00
The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00
The impact of radiation therapy sequencing on survival and cardiopulmonary mortality in the combined modality treatment of patients with esophageal cancer. Cancer (2013) 1.97
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol (2002) 1.93
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89
Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med (2009) 1.89
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis (2004) 1.88
Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant (2010) 1.85
Whole-exome sequencing links a variant in DHDDS to retinitis pigmentosa. Am J Hum Genet (2011) 1.85
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol (2004) 1.83
Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol (2012) 1.83
Public preferences about secondary uses of electronic health information. JAMA Intern Med (2013) 1.82
Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups. Pharmacogenomics (2010) 1.82
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis (2008) 1.82
Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 1.80
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79